Loading…

Medical Research Finder

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

Dysbiosis & Hepatocellular carcinoma (HCC)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Dysbiosis contributes to the pathogenesis of HCC by transporting PAMPs such as bacterial lipopolysaccharides , DNA, peptidoglycans, and flagellin to the liver.
Russo et al. 2022 World J Hepatol 14(2): 372-385
Silveira et al. 2022 Trends in Cancer 8: 583

In Hepatocellular Carcinoma (HCC), inadequate [immune surveillance](brain://PiixZVvHT1…

A different gut microbiome linked to inﬂammation found in cirrhotic patients with and without hepatocellular carcinoma
Pinero et al. 2019 Ann. Hepatol. 18: 480-487
Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma
Ren et al. 2019 Gut 68: 1014–1023
Hepatocellular carcinoma is associated with gut microbiota proﬁle and inﬂammation in nonalcoholic fatty liver disease
Ponziani et al. 2019 Hepatology 69: 107-120
Profile of gut microbiota associated with the presence of hepatocellular cancer in patients with liver cirrhosis
Grąt et al. 2016 Transplant Proc 48:1687-1691
Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats
Zhang et al. 2012b J Hepatol 57: 803-812
The gut–liver axis and the intersection with the microbiome
Tripathi et al. 2018
Review
The gut–liver axis: host microbiota interactions shape hepatocarcinogenesis
Silveira et al. 2022 Trends in Cancer 8: 583
Review

7/1/2026